The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...
GlobalData on MSN16h
Roche secures CE mark for ovarian cancer detection testRoche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
Executive Vice-President of Diagnostics, Africa, at Roche Diagnostics, Dr. Allan Pamba ... to diagnostics and integrating self-monitoring into routine care, enabling us to control our health,” he said ...
Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
Kazmierczak also appreciates that flexibility. “Roche provides phenomenal work-life balance, with great benefits, making it ...
Andrews Joins as CEO's Strategic Consultant to Accelerate Growth Initiatives BINYAMINA, Israel and CARY, N.C, Nov. 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback